MA26993A1 - 6-pyridopyrimidines substitues - Google Patents

6-pyridopyrimidines substitues

Info

Publication number
MA26993A1
MA26993A1 MA27273A MA27273A MA26993A1 MA 26993 A1 MA26993 A1 MA 26993A1 MA 27273 A MA27273 A MA 27273A MA 27273 A MA27273 A MA 27273A MA 26993 A1 MA26993 A1 MA 26993A1
Authority
MA
Morocco
Prior art keywords
pyridopyrimidines
substituted
substituted pyridopyrimidines
Prior art date
Application number
MA27273A
Other languages
English (en)
Inventor
Jian Jeffrey Chen
James Patrick Dunn
David Michael Goldstein
Christoph Martin Stahl
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA26993A1 publication Critical patent/MA26993A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MA27273A 2001-02-12 2003-08-11 6-pyridopyrimidines substitues MA26993A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26837501P 2001-02-12 2001-02-12
US33465401P 2001-11-30 2001-11-30

Publications (1)

Publication Number Publication Date
MA26993A1 true MA26993A1 (fr) 2004-12-20

Family

ID=26953040

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27273A MA26993A1 (fr) 2001-02-12 2003-08-11 6-pyridopyrimidines substitues

Country Status (32)

Country Link
US (3) US6696566B2 (fr)
EP (1) EP1361880B1 (fr)
JP (1) JP4064818B2 (fr)
KR (1) KR100639772B1 (fr)
CN (1) CN100376571C (fr)
AR (1) AR035854A1 (fr)
AT (1) ATE305303T1 (fr)
AU (1) AU2002256615B2 (fr)
BR (1) BRPI0207172B8 (fr)
CA (1) CA2434834C (fr)
CZ (1) CZ20032416A3 (fr)
DE (1) DE60206363T2 (fr)
DK (1) DK1361880T3 (fr)
ES (1) ES2249574T3 (fr)
HK (1) HK1066170A1 (fr)
HR (1) HRP20030624B1 (fr)
HU (1) HU229604B1 (fr)
IL (2) IL156872A0 (fr)
JO (1) JO2410B1 (fr)
MA (1) MA26993A1 (fr)
MX (1) MXPA03007166A (fr)
MY (1) MY131518A (fr)
NO (1) NO326133B1 (fr)
NZ (1) NZ526961A (fr)
PA (1) PA8539201A1 (fr)
PE (1) PE20020976A1 (fr)
PL (1) PL366918A1 (fr)
RU (1) RU2269527C2 (fr)
SK (1) SK11322003A3 (fr)
WO (1) WO2002064594A2 (fr)
YU (1) YU63703A (fr)
ZA (1) ZA200305938B (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053070B2 (en) * 2000-01-25 2006-05-30 Warner-Lambert Company Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors
IL156872A0 (en) 2001-02-12 2004-02-08 Hoffmann La Roche 6-substituted pyrido-pyrimidines
DK1470124T3 (da) * 2002-01-22 2006-04-18 Warner Lambert Co 2-(Pyridin-2-yl amino)-pyrido[2,3]pyrimidin-7-oner
JP2006503802A (ja) 2002-04-03 2006-02-02 エフ．ホフマン−ラ　ロシュ　アーゲー イミダゾ縮合化合物
MXPA05001332A (es) * 2002-08-06 2005-04-28 Hoffmann La Roche 6-alcoxi-pirido-pirimidinas como inhibidores de cinasa del map p-38.
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
AP2114A (en) * 2003-02-26 2010-03-04 Sugen Inc Aminoheteroaryl compounds as protein kinase inhibitors
JP2006523640A (ja) * 2003-04-16 2006-10-19 エフ．ホフマン−ラ　ロシュ　アーゲー 置換７−アザ−キナゾリン化合物
PL1685131T3 (pl) * 2003-11-13 2007-08-31 Hoffmann La Roche Hydroksyalkilo-podstawione pirydo-7-pirymidyn-7-ony
US20090131430A1 (en) * 2004-11-23 2009-05-21 Palle Venkata P Pyrido'2,3-dipyrimidines as anti-inflammatory agents
US20060142312A1 (en) * 2004-12-23 2006-06-29 Pfizer Inc C6-aryl and heteroaryl substituted pyrido[2,3-D] pyrimidin-7-ones
EP1846403A1 (fr) * 2005-02-02 2007-10-24 Ranbaxy Laboratories Limited Derives azabicyclo utilises comme agents anti-inflammatoires
EP1885369B1 (fr) * 2005-05-04 2015-09-23 Evotec AG Composes heterocycliques fusionnes, leurs compositions et leurs utilisations
ATE449097T1 (de) * 2005-07-21 2009-12-15 Hoffmann La Roche Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer
JP2009504665A (ja) * 2005-08-09 2009-02-05 アイアールエム・リミテッド・ライアビリティ・カンパニー タンパク質キナーゼ阻害剤としての化合物および組成物
EP1917245A1 (fr) 2005-08-21 2008-05-07 Abbott GmbH & Co. KG Composes heterocycliques et leur utilisation en tant que partenaires de liaison des recepteurs 5-ht5
JO2783B1 (en) * 2005-09-30 2014-03-15 نوفارتيس ايه جي Compounds 2-Amino-7, 8-dihydro-6H-Bayredo (3,4-D) Pyrimidine-5-Ones
WO2008150260A1 (fr) * 2007-06-06 2008-12-11 Gpc Biotech, Inc. Inhibiteurs de kinase
WO2008078249A1 (fr) * 2006-12-21 2008-07-03 Ranbaxy Laboratories Limited Agents anti-inflammatoires
WO2008136948A1 (fr) 2007-05-07 2008-11-13 Amgen Inc. Composés pyrazolo-pyridinone et pyrazolo-pyrazinone servant de modulateurs de p38, leur procédé de préparation et leur procédé d'utilisation pharmaceutique
CA2690327A1 (fr) 2007-06-15 2008-12-18 Thomas P. Cleary Nouveau procede de preparation de 3-amino-pentan-1,5-diol
US8367671B2 (en) 2008-03-21 2013-02-05 Amgen Inc. Pyrazolo[3.4-B]pyrazine compounds as p38 modulators and methods of use as anti-inflamatory agents
EP2112150B1 (fr) 2008-04-22 2013-10-16 Forma Therapeutics, Inc. Inhibiteurs Raf améliorés
EP2344502A2 (fr) * 2008-10-22 2011-07-20 F. Hoffmann-La Roche AG Inhibiteurs pyrimidinylpyridone de jnk
WO2010071846A2 (fr) 2008-12-19 2010-06-24 Afraxis, Inc. Composés pour traiter des états neuropsychiatriques
WO2011044535A2 (fr) 2009-10-09 2011-04-14 Afraxis, Inc. 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones pour le traitement de troubles de snc
US8889696B2 (en) * 2009-12-18 2014-11-18 Temple University—Of the Commonwealth System of Higher Education Substituted pyrido[2,3-d]pyrimidin-7(8H)-ones and therapeutic uses thereof
JP6631616B2 (ja) 2014-07-26 2020-01-15 ノース・アンド・サウス・ブラザー・ファーマシー・インベストメント・カンパニー・リミテッド ＣＤＫ阻害剤としての２−アミノ−ピリド［２，３−ｄ］ピリミジン−７（８Ｈ）−オン誘導体及びその使用
HUE053648T2 (hu) * 2016-06-08 2021-07-28 Support Venture Gmbh Gyógyászati kombinációk rák kezelésére
HUE055978T2 (hu) 2016-08-15 2022-01-28 Pfizer Piridopirimidinon CDK2/4/6 inhibitorok
EP3500258A1 (fr) 2016-08-17 2019-06-26 Support-Venture GmbH Méthode de prévention ou de traitement de la perte audititive.
WO2018132550A1 (fr) 2017-01-11 2018-07-19 The General Hospital Corporation Agents d'imagerie à canaux sodiques dépendant de la tension
SG10202110804WA (en) 2017-04-04 2021-11-29 Kinarus Ag Methods of preventing or treating ophthalmic diseases
EP3676267A4 (fr) 2017-08-31 2021-04-14 Dana Farber Cancer Institute, Inc. Inhibiteurs d'egfr et/ou de her2 et procédés d'utilisation
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
PT3691620T (pt) 2017-10-05 2022-10-06 Fulcrum Therapeutics Inc Os inibidores da quinase p38 reduzem a expressão de dux4 e genes a jusante para o tratamento de fshd
WO2020006210A1 (fr) * 2018-06-27 2020-01-02 Tufts Medical Center, Inc. Composés pyridopyrimidine et leurs méthodes d'utilisation
MA53114A (fr) 2018-07-13 2021-05-19 Kinarus Ag Combinaisons d'agonistes de ppar et d'inhibiteurs de kinase p38 pour prévenir ou traiter des maladies fibrotiques
TW202112368A (zh) 2019-06-13 2021-04-01 荷蘭商法西歐知識產權股份有限公司 用於治療有關dux4表現之疾病的抑制劑組合
US20230263803A1 (en) 2020-08-11 2023-08-24 Kinarus Ag Methods of preventing or treating covid-19 and related viral diseases or disorders

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215216A (en) 1979-04-18 1980-07-29 American Home Products Corporation 7,8-Dihydro-2,5,8-trisubstituted-7-oxo-pyrido[2,3-d]pyrimidine-6-carboxylic acid derivatives
US5037826A (en) 1986-10-15 1991-08-06 Schering Corporation 1-substituted naphthyridine and pyridopyrazine derivatives
GB8702758D0 (en) * 1987-02-06 1987-03-11 Wellcome Found Treatment of disease
AU598093B2 (en) 1987-02-07 1990-06-14 Wellcome Foundation Limited, The Pyridopyrimidines, methods for their preparation and pharmaceutical formulations thereof
WO1993017682A1 (fr) 1992-03-04 1993-09-16 Abbott Laboratories Antagonistes des recepteurs de l'angiotensine ii
ES2146782T3 (es) * 1994-11-14 2000-08-16 Warner Lambert Co 6-aril-pirido(2,3-d)pirimidinas y naftiridinas para la inhibicion de la proliferacion celular inducida por la proteina tirosina quinasa.
IL115256A0 (en) 1994-11-14 1995-12-31 Warner Lambert Co 6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
IL117923A (en) * 1995-05-03 2000-06-01 Warner Lambert Co Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
US5620981A (en) 1995-05-03 1997-04-15 Warner-Lambert Company Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
AR004010A1 (es) 1995-10-11 1998-09-30 Glaxo Group Ltd Compuestos heterociclicos
US6107300A (en) 1996-03-27 2000-08-22 Dupont Pharmaceuticals Arylamino fused pyrimidines
US6147080A (en) * 1996-12-18 2000-11-14 Vertex Pharmaceuticals Incorporated Inhibitors of p38
US5945422A (en) 1997-02-05 1999-08-31 Warner-Lambert Company N-oxides of amino containing pyrido 2,3-D! pyrimidines
ATE391719T1 (de) 1997-02-05 2008-04-15 Warner Lambert Co Pyrido (2,3-d) pyrimidine und 4-amino-primidine als inhibitoren der zellulären proliferation
TW458977B (en) * 1997-04-16 2001-10-11 Abbott Lab 6,7-disubstituted-4-aminopyrido[2,3-D] pyrimidine compounds
HUP0001443A3 (en) 1997-04-16 2001-01-29 Abbott Lab 5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds, pharmaceutical compositions thereof and process for preparing them
BR9809055A (pt) 1997-04-16 2000-08-08 Abbott Lab Compostos de 4-amino-pirido(2,3-d)pirimidina 5,7-dissubstituìda e seu uso como inibidores de adenosinocinase
AU763839B2 (en) 1998-05-26 2003-07-31 Warner-Lambert Company Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
EA005852B1 (ru) 1998-06-19 2005-06-30 Пфайзер Продактс Инк. ПИРРОЛО[2,3-d]ПИРИМИДИНЫ
EP1078923B1 (fr) 1999-08-02 2006-03-08 F. Hoffmann-La Roche Ag Procédé de préparation de dérivés de benzothiophène
US7053070B2 (en) * 2000-01-25 2006-05-30 Warner-Lambert Company Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors
WO2001070741A1 (fr) * 2000-03-06 2001-09-27 Warner-Lambert Company Inhibiteurs de tyrosine kinase a base de 5-alkylpyrido[2,3-d]pyrimidines
US6518276B2 (en) * 2000-08-31 2003-02-11 Syntex (U.S.A.) Llc 7-oxo-pyridopyrimidines (II)
IL156872A0 (en) 2001-02-12 2004-02-08 Hoffmann La Roche 6-substituted pyrido-pyrimidines
DK1470124T3 (da) * 2002-01-22 2006-04-18 Warner Lambert Co 2-(Pyridin-2-yl amino)-pyrido[2,3]pyrimidin-7-oner

Also Published As

Publication number Publication date
US7449581B2 (en) 2008-11-11
PE20020976A1 (es) 2002-10-29
DE60206363D1 (de) 2006-02-09
NO326133B1 (no) 2008-10-06
NZ526961A (en) 2005-03-24
NO20033540L (no) 2003-08-11
ZA200305938B (en) 2005-01-26
RU2269527C2 (ru) 2006-02-10
MXPA03007166A (es) 2003-11-18
HU229604B1 (en) 2014-02-28
ES2249574T3 (es) 2006-04-01
KR100639772B1 (ko) 2006-10-30
US7169794B2 (en) 2007-01-30
BRPI0207172B1 (pt) 2019-04-09
PA8539201A1 (es) 2004-08-31
DE60206363T2 (de) 2006-07-06
EP1361880A2 (fr) 2003-11-19
HRP20030624A2 (en) 2005-06-30
CZ20032416A3 (cs) 2004-07-14
JO2410B1 (en) 2007-06-17
US20070135458A1 (en) 2007-06-14
IL156872A (en) 2009-07-20
DK1361880T3 (da) 2006-01-23
PL366918A1 (en) 2005-02-07
BRPI0207172B8 (pt) 2021-05-25
IL156872A0 (en) 2004-02-08
US20030171584A1 (en) 2003-09-11
ATE305303T1 (de) 2005-10-15
JP2004525896A (ja) 2004-08-26
JP4064818B2 (ja) 2008-03-19
HK1066170A1 (en) 2005-03-18
NO20033540D0 (no) 2003-08-11
AU2002256615B2 (en) 2007-09-13
BR0207172A (pt) 2004-03-30
WO2002064594A3 (fr) 2003-01-09
CN1503672A (zh) 2004-06-09
AR035854A1 (es) 2004-07-21
MY131518A (en) 2007-08-30
EP1361880B1 (fr) 2005-09-28
CA2434834A1 (fr) 2002-08-22
RU2003125887A (ru) 2005-03-20
CN100376571C (zh) 2008-03-26
HRP20030624B1 (en) 2007-03-31
HUP0303458A2 (hu) 2004-01-28
US6696566B2 (en) 2004-02-24
US20040116698A1 (en) 2004-06-17
HUP0303458A3 (en) 2012-12-28
KR20040018254A (ko) 2004-03-02
YU63703A (sh) 2006-05-25
WO2002064594A2 (fr) 2002-08-22
SK11322003A3 (en) 2004-10-05
CA2434834C (fr) 2010-09-14

Similar Documents

Publication Publication Date Title
MA26993A1 (fr) 6-pyridopyrimidines substitues
IS7291A (is) Merkt kirni
DE60230584D1 (de) Fensterheber
DE60235777D1 (de) Verschleissanordnung
DE60232264D1 (de) Suburethrale/zervikale ministütze
DE60232603D1 (de) Nahinfrarot-schutzfolie
DE60227724D1 (de) Spülrohranordnung
ATE524462T1 (de) C5-modifizierte indazolylpyrrolotriazine
DE60202573D1 (de) Permeameter-Porosimeter
ATE312827T1 (de) 3-substituierte-4-pyrimidonderivate
DE60227839D1 (de) Martensitische nanoverbundstähle
DE60213088D1 (de) Chromen-verbindungen
DE60135540D1 (de) noporen
DE60205841D1 (de) Perfluoroelastomere
DE60201341D1 (de) Hochbahn
DE60231527D1 (de) Aerosolspritzdüse
DE50207739D1 (de) Kombinationswerkzeug
DE60202533D1 (de) Verschlusskappe
DE50208372D1 (de) Schrankaufhängevorrichtung
DE60130930D1 (de) Polarisationsmodendispersion-kompensator
DE60213695D1 (de) Differentialeinheit
ATE355059T1 (de) Isoxazolopyridinone
DK1467802T3 (da) Nedfiringsanordning
DE60206350D1 (de) Ozonisator
DE50212426D1 (de) Bohrwerkzeug